Moteur de recherche d’entreprises européennes
Registre de Transparence de l'Union Européenne Eutr07/02/2026 Registre de Transparence de l'Union Européenne
Vue d’ensemble
Texte
Bayer AG
Registration ID: 3523776801-85 Registration Date: December 17, 2008 Last Update Date: February 5, 2026 Website: www.bayer.com Entity Form: Company / Aktiengesellschaft Registration Category: Companies & groups
About Bayer AG
Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. The Bayer Group is managed as a life science company with three divisions – Pharmaceuticals, Consumer Health and Crop Science, which are also our reporting segments. The Enabling Functions support the operational business.
Contact Information
Head Office: Bayer AG 51368 Leverkusen GERMANY Phone: +49 2143052657
EU Office: 40 Rue Belliard 1040 Brussels BELGIUM Phone: +32 25502112
Levels of Interest
- National
- European
- Global
- Sub-national
Interests
- Agriculture and rural development
- Banking and financial services
- Business and industry
- Climate action
- Competition
- Consumers
- Customs
- Digital economy and society
- Economy, finance and the euro
- Energy
- Environment
- Food safety
- Institutional affairs
- Public health
- Research and innovation
- Single market
- Taxation
- Trade
EU Legislative Proposals and Policy Areas
Bayer engages with policy areas related to pharmaceutical, crop protection, seeds, and corporate legislations and regulations, as well as policies in the area of trade, industry, intellectual property, environmental protection, chemical policy, agricultural policy, digital policy, taxation, innovation and research, development policy, and pesticide regulations.
Some specific legislative proposals and policy areas include:
- A Vision for Agriculture and Food (Farm to Fork Strategy)
- CAP post-2027
- EU Biodiversity Strategy for 2030
- Chemicals Strategy for Sustainability
- Zero Pollution Action Plan
- Soil Monitoring and Resilience Law
- EU Enlargement Strategy
- Sustainable Products Initiative
- Sustainable Food System Framework
- Protection of groundwater & Environmental Quality Standards
- Packaging and Packaging Waste
- Amendment of Water Framework Directive
- Urban Waste Water Treatment Directive (recast)
- Carbon Removal Certification Framework
- Revision of EU Climate Law (2040 target)
- Plant Reproductive Material
- Plant Protection Products & labelling
- Industrial Emissions Directive (recast)
- Multiannual Financial Framework 2028–2034
- EU General Pharmaceuticals Legislation
- European Health Data Space
- Farm Sustainability Data Network
- Health Technology Assessment
- Safe and Sustainable by Design Framework
- Revision of Water Directives package
- Titanium Dioxide (E171) ban
- EU Beating Cancer Plan
- REACH revision
- PFAS restriction – REACH Annex XV restriction proposal (ECHA, 2023)
- CLP Regulation revision
- EU Taxonomy Regulation
- European Data Governance Act
- EU Intellectual Property Package
- EU Artificial Intelligence Act
- Prohibition of export of banned chemicals
- Maximum residue levels of pesticides
- European Climate Resilience & Risk Management Initiative
- Nature Restoration Law
- EU Deforestation Regulation
- CSRD/CSDDD alignment directive
- Amendment of Industrial Emissions Directive
- ESG Rating Agencies Regulation
- Green Claims Directive
- Revised Product Liability Directive
- Forced Labour Regulation
- EU Trade Policy Review / FTAs
- EU Economic Security Strategy
- European Biotech Act I
- On-farm sustainability compass
- PPP record-keeping implementing act
- EU Safe Hearts Plan
- Common data platform on chemicals
- Re-attribution of tasks among EU chemicals agencies
- EU Critical Medicines Act
- Unilateral trade measures / FDI screening
- Revision of vitamins & minerals Directive
- New Genomic Techniques
- EU-Mercosur safeguard regulation
- Omnibus VII – Food and Feed Safety
- Omnibus I (CSRD, CSDDD, Taxonomy)
- Roadmap towards Nature Credits
- EU Bioeconomy Strategy
- European Water Resilience Strategy
- Revision of Implementing Regulation (EU) 2022/996
- Adjustment of customs duties on US goods
- EU Dangerous Goods Regulation
- Directive on deliberate release of Genetically Modified Organisms and the recent proposal to amend it
- GM food and feed and its implementing regulation (EU) No. 503/2013
- Plant Reproductive Material – proposal for a regulation replacing several directives
- Delegated regulation supplementing regulation 2024/3012 by establishing methodologies for carbon farming activities
- European Climate Resilience and Risk Management – Integrated Framework
- Omnibus VI - Chemicals
- Omnibus VII - Digital
- European Health Data Space Regulation
EU Supported Forums and Platforms
- Innovative Medicines Initiative
- Innovative Health Initiative
- Horizon2020
- Horizon Europe
- Beating Cancer Stakeholder Group
- EU Pharma Market Access Group
- EU Agri-food Platform
- ACT EU
- EU Transition Pathways Platform
Communication Activities
Bayer engages in communication and public relations activities to support its political initiatives and aims. This includes engagement with media on innovation and science, as well as events in cooperation with other organizations. Bayer adheres to high ethical standards for media engagement and ensures transparency of its positions.
Bayer sponsors content and events organized by Politico as part of the "Drive sustainable progress" campaign. More information can be found at: https://www.politico.eu/sponsored-content/drive-sustainable-progress-hub/
Other activities supported or organized in 2025 include:
- EFPIA - Europe's Choice Campaign
- Bayer - Back to Growth event in Brussels
Inter or Unofficial Groupings
- Unofficial groupings, Cancer and Rare Diseases
Members
- Total Members: 66
- FTE Members: 20
- EP Accredited Number: 8
The number of persons involved in relevant activities includes staff in the Bayer EU Public Affairs Office, headquarters, and EU member states. Staff outside Brussels are also involved in activities falling under the EU Transparency Register, for instance, through representation in EU trade associations.
Structure
The Bayer EU Public Affairs office represents Bayer AG and all its affiliates at EU level. Further information can be found at: https://www.bayer.com/
Bayer is directly a member of the following associations, networks, or platforms at the EU level:
- Business Europe
- European Chemical Industry Council (CEFIC)
- FluoroProducts and PFAS for Europe (FPP4EU)
- European Federation of Pharmaceutical Industries Association (EFPIA)
- The Association of the European Self-Medication Industry (AESGP)
- CropLife Europe (CLE)
- Euroseeds
- Cosmetics Europe
- DIGITALEUROPE
- European Justice Forum
- Food Supplements Europe
- MedTech Europe
- European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry (COCIR)
- Nuclear Medicines Europe (NMEU)
- The Alliance for Regenerative Medicine (ARM)
- European Biostimulants Council (EBIC)
- MedTech & Pharma Platform
- European Health Summits (EBS)
- The Public Affairs Council
- The Ad Hoc Partnership Limited
- Conseil de Cooperation Economique (CCE)
The company also supports a network of stakeholders in the area of innovation, health, trade, agricultural, and chemical policy, which includes:
- Farm Europe
- Plants for the Future European Technology Platform (Plant ETP)
- Friends of the Countryside
- The Glyphosate Renewal Group
- Chemleg European Notification Panel (ENP)
- EURORDIS (European Organisation for Rare Diseases)
- EIT Food
- EU Critical Medicines Alliance
- EU Critical Chemicals Alliance
- The Ad-hoc Annex IX Industry Coalition
Interest Represented
Promotes their own interests or the collective interests of their members.
Financial Data
Closed Year (2025)
- Start Date: January 1, 2025
- End Date: December 1, 2025
- Total Costs: €6,000,000 - €6,499,999
Intermediaries:
| Intermediary Name | Representation Costs (€) |
|---|---|
| Dario Ruivo Lda. | < 10,000 |
| RPP Group | 100,000 - 199,999 |
| EUTOP Europe GmbH | 400,000 - 499,999 |
| EU Strategy | 25,000 - 49,999 |
| Penta (formerly Hume Brophy) | 25,000 - 49,999 |
| Rud Pedersen Public Affairs Brussels | 600,000 - 699,999 |
| EPPA SA | 50,000 - 99,999 |
| Burson Cohn & Wolfe SRL | 10,000 - 24,999 |
Grants:
| Source | Amount (€) |
|---|---|
| EU framework (H2020, HE2020, MarieCurie) | 285,000 |
Current Year
Intermediaries:
- EUTOP Europe GmbH
- Rud Pedersen Public Affairs Brussels
- Penta
- BOLDT
- FGS Global (Belgium) BV
Grants: None reported for the current year.
Complementary Information
Transparency is a top priority for Bayer. We are committed to strengthening trust by making information accessible from a whole range of areas, including our political engagement. We have established our own code of conduct for responsible lobbying (publicly available on our website) many years ago and declare our lobbying costs in our annual report. We furthermore publish an annual global Political Advocacy Transparency Report.
Bayer, in addition to the costs of its EU Public Affairs Office, included the expenses of its business divisions providing e.g., background research, position papers, political work within European associations, and visits to Brussels related to activities falling under the scope of the register. Following the rules of the Transparency Register, Bayer included all relevant costs for intermediary contracts falling under the scope and definition of the register. Relevant shares of communication activities as described under heading 9 are included in the total annual costs declared.
Bayer is a member of various trade associations, independently reporting in the transparency register. Membership fees to these trade associations are used for a wide array of activities, including the independent representation of industry interests. The 2025 estimates are in some limited cases not yet available and will be provided in due time. It should be noted that these fees are also being reported in the budgets of the trade associations, thus effectively resulting in a double reporting.
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Bayer AG, Leverkusen, Allemagne.
